Table 1.
Trial | Enrollment | ClinicalTrials.gov ID |
---|---|---|
Metronidazole PK in infants | 24 | NCT01222585 |
Acyclovir PK in infants | 32 | NCT00491426 |
TAPE device trial | 625 | NCT01507090 |
Hydroxyurea PK | 40 | NCT01506544 |
POPS | 2100 | NCT01431326 |
Lisinopril PK in children with renal transplants | 26 | NCT01491919 |
Staph trio | 63 | NCT01728363 |
Sildenafil PK in infants | 25 | NCT01670136 |
Clindamycin in obese children | 23 | NCT01744730 |
Methadone PK in children | 26 | NCT01945736 |
SCAMP | 140 | NCT01994993 |
Pantoprazole PK in obese children | 41 | NCT02186652 |
Baby TAPE | 2000 | N/A |
Furosemide safety in infants | 5 | NCT02527798 |
POPS = Pharmacokinetics of understudied drugs administered to children per standard of care; SCAMP = Safety study of Clindamycin, Ampicillin, Metronidazole, and Piperacillin-tazobactam in infants with complicated intra-abdominal infections.